(19)
(11) EP 0 954 278 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.06.2005 Bulletin 2005/24

(45) Mention of the grant of the patent:
20.04.2005 Bulletin 2005/16

(21) Application number: 97912824.6

(22) Date of filing: 27.10.1997
(51) International Patent Classification (IPC)7: A61K 7/48, A61K 35/78
(86) International application number:
PCT/US1997/018981
(87) International publication number:
WO 1998/020852 (22.05.1998 Gazette 1998/20)

(54)

PHARMACEUTICAL COMPOSITIONS CONTAINING KUKUI NUT OIL

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN WELCHE KUKUI NUSS ÖL ENTHALTEN

COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'HUILE DE NOIX DE KUKUI

(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV RO SI

(30) Priority: 12.11.1996 US 32048 P

(43) Date of publication of application:
10.11.1999 Bulletin 1999/45

(73) Proprietor: Pharmacia & Upjohn Company LLC
Kalamazoo, MI 49001 (US)

(72) Inventor:
  • MUNDEN, James, W.
    Portage, MI 49024 (US)

(74) Representative: Perry, Robert Edward 
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH
London EC2M 7LH (GB)


(56) References cited: : 
WO-A-85/00746
US-A- 4 154 823
 DE-A- 4 405 127
US-A- 5 279 817
   
  • DATABASE WPI Week 9514 Derwent Publications Ltd., London, GB; AN 95-101776 XP002052527 & JP 07 025 741 A (SANSEI SEIYAKU KK)
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).